IL205780A - Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii - Google Patents

Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii

Info

Publication number
IL205780A
IL205780A IL205780A IL20578010A IL205780A IL 205780 A IL205780 A IL 205780A IL 205780 A IL205780 A IL 205780A IL 20578010 A IL20578010 A IL 20578010A IL 205780 A IL205780 A IL 205780A
Authority
IL
Israel
Prior art keywords
vivo
factor viii
synthetic peptides
peptides capable
inhibitor antibodies
Prior art date
Application number
IL205780A
Other languages
English (en)
Hebrew (he)
Other versions
IL205780A0 (en
Original Assignee
Apitope Int Nv
Apitope Technology Bristol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Int Nv, Apitope Technology Bristol Ltd filed Critical Apitope Int Nv
Publication of IL205780A0 publication Critical patent/IL205780A0/en
Publication of IL205780A publication Critical patent/IL205780A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL205780A 2007-12-04 2010-05-13 Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii IL205780A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0723712.6A GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides
PCT/GB2008/003996 WO2009071886A1 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs

Publications (2)

Publication Number Publication Date
IL205780A0 IL205780A0 (en) 2010-11-30
IL205780A true IL205780A (en) 2015-06-30

Family

ID=38982965

Family Applications (1)

Application Number Title Priority Date Filing Date
IL205780A IL205780A (en) 2007-12-04 2010-05-13 Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii

Country Status (25)

Country Link
US (1) US8445448B2 (enExample)
EP (1) EP2227488B3 (enExample)
JP (2) JP5501245B2 (enExample)
KR (1) KR101519840B1 (enExample)
CN (2) CN103709234B (enExample)
AU (1) AU2008332968B2 (enExample)
BR (1) BRPI0820143A2 (enExample)
CA (2) CA2707559C (enExample)
CY (1) CY1115168T1 (enExample)
DK (1) DK2227488T6 (enExample)
EA (1) EA019370B1 (enExample)
EC (1) ECSP10010327A (enExample)
ES (1) ES2458315T7 (enExample)
GB (1) GB0723712D0 (enExample)
HR (1) HRP20140344T4 (enExample)
IL (1) IL205780A (enExample)
MX (1) MX2010006084A (enExample)
MY (1) MY150995A (enExample)
NZ (1) NZ585217A (enExample)
PL (1) PL2227488T6 (enExample)
PT (1) PT2227488E (enExample)
SI (1) SI2227488T1 (enExample)
UA (1) UA101003C2 (enExample)
WO (1) WO2009071886A1 (enExample)
ZA (1) ZA201002997B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030062321A (ko) 2000-08-21 2003-07-23 아피토프 테크놀러지 (브리스톨) 리미티드 펩티드 선별 방법
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
US8329871B2 (en) * 2008-06-24 2012-12-11 Octapharma Ag Process of purifying coagulation factor VIII
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
US20120135917A1 (en) * 2009-06-16 2012-05-31 Eisaku Yoshihara Anti-Gram Negative Bacteria Agent
PL3260132T3 (pl) * 2010-10-27 2022-08-08 Takeda Pharmaceutical Company Limited Peptydy fviii do wywoływania tolerancji immunologicznej oraz immunodiagnostyki
EA038705B1 (ru) 2012-01-12 2021-10-07 Биовератив Терапьютикс Инк. Способы снижения иммуногенности фактора свёртывания крови viii у пациентов, получающих лечение фактором viii
CN104903347B (zh) * 2012-11-12 2020-02-21 艾匹托普国际股份有限公司 肽
GB201314052D0 (en) 2013-08-06 2013-09-18 Apitope Int Nv Peptides
MX2018006789A (es) 2015-12-03 2019-02-13 Juno Therapeutics Inc Receptores quimericos modificados y composiciones y metodos relacionados.
CA3044838A1 (en) 2016-12-02 2018-06-07 Bioverativ Therapeutics Inc. Methods of inducing immune tolerance to clotting factors
US12077607B2 (en) * 2021-09-23 2024-09-03 University Of Utah Research Foundation Functional and therapeutic effects of PAR4 cleavage by cathepsin G

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015615A1 (en) * 1989-06-20 1990-12-27 Scripps Clinic And Research Foundation The phospholipid binding domain of factor viii
US6132729A (en) * 1997-01-22 2000-10-17 Board Of Regents, The University Of Texas System Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment
KR20030062321A (ko) 2000-08-21 2003-07-23 아피토프 테크놀러지 (브리스톨) 리미티드 펩티드 선별 방법
US20040096456A1 (en) * 2000-12-01 2004-05-20 Conti-Fine Bianca M Method to treat hemophilia
PL362324A1 (en) * 2001-02-19 2004-10-18 Merck Patent Gmbh Artificial fusion proteins with reduced immunogenicity
AU2002312660A1 (en) * 2001-05-31 2002-12-16 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
MXPA04010061A (es) * 2002-04-18 2004-12-13 Merck Patent Gmbh Factor viii modificado.
CN102816241B (zh) * 2004-02-09 2015-07-22 人类基因科学公司 清蛋白融合蛋白
WO2006003183A1 (de) 2004-07-02 2006-01-12 Alois Jungbauer Peptide zur blockierung von fviii-inhibitoren
IL229645A0 (en) * 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin

Also Published As

Publication number Publication date
BRPI0820143A2 (pt) 2015-05-12
ZA201002997B (en) 2011-07-27
CN101889024B (zh) 2014-04-23
JP6063402B2 (ja) 2017-01-18
JP2014088440A (ja) 2014-05-15
NZ585217A (en) 2012-11-30
CA3005013C (en) 2021-11-16
CA2707559C (en) 2018-07-03
GB0723712D0 (en) 2008-01-16
UA101003C2 (uk) 2013-02-25
PL2227488T3 (pl) 2014-07-31
ES2458315T3 (es) 2014-04-30
ECSP10010327A (es) 2010-09-30
SI2227488T1 (sl) 2014-06-30
CN103709234B (zh) 2017-01-18
AU2008332968B2 (en) 2014-03-20
EA201070681A1 (ru) 2010-10-29
IL205780A0 (en) 2010-11-30
EP2227488B1 (en) 2014-01-22
CA3005013A1 (en) 2009-06-11
PL2227488T6 (pl) 2015-04-30
MX2010006084A (es) 2010-06-23
MY150995A (en) 2014-03-31
HRP20140344T1 (en) 2014-05-09
KR20100087346A (ko) 2010-08-04
JP5501245B2 (ja) 2014-05-21
CY1115168T1 (el) 2016-12-14
CN101889024A (zh) 2010-11-17
HK1144292A1 (en) 2011-02-11
ES2458315T7 (es) 2015-02-18
JP2011505414A (ja) 2011-02-24
KR101519840B1 (ko) 2015-05-18
EP2227488A1 (en) 2010-09-15
PT2227488E (pt) 2014-04-21
AU2008332968A1 (en) 2009-06-11
CN103709234A (zh) 2014-04-09
DK2227488T6 (en) 2015-02-16
HRP20140344T4 (hr) 2015-07-31
WO2009071886A1 (en) 2009-06-11
US8445448B2 (en) 2013-05-21
EA019370B1 (ru) 2014-03-31
EP2227488B3 (en) 2014-11-19
US20100323966A1 (en) 2010-12-23
CA2707559A1 (en) 2009-06-11
DK2227488T3 (da) 2014-04-22

Similar Documents

Publication Publication Date Title
IL200030A0 (en) Improvement of protein production
GB0700523D0 (en) The Stabilisation Of Proteins
SI3178490T1 (sl) Sestavki proteina F RSV-ja in postopki za pripravo le-teh
ZA201100290B (en) Soluble canola protein isolate production
ZA201200200B (en) Chimaeric protein
IL236236A (en) Antibodies to the fam26f polypeptide
EP2576593A4 (en) PROCESS FOR THE SYNTHESIS OF DICARBA BRIDGES IN PEPTIDES
IL214375A0 (en) Novel peptides and methods for producing them
GB0723712D0 (en) Peptides
GB0920981D0 (en) Peptides
ZA201008279B (en) Novel canola protein isolate
GB0816976D0 (en) Protein
GB0724953D0 (en) Methods of peptide modification
GB0801513D0 (en) Peptides from factor VIII
GB0920987D0 (en) Peptides
GB0707638D0 (en) Methods of manufacture of extended area articles
GB0812586D0 (en) Chimaeric peptide
GB2462726B (en) Protein expression
GB0715325D0 (en) Fertilisation protein
HU0900712D0 (en) New methods and intermediers for the synthesis of ace-inhibitor
GB0817978D0 (en) Peptides
GB0818627D0 (en) Protein
GB0710858D0 (en) Methods for the synthesis of peptides
GB0813006D0 (en) The stabilisation of proteins
IL213454A0 (en) Isolated peptides of rabbit factor v11

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed